May. 06, 2011

Navitar Life Sciences Acquires Assets of Modulation Optics and HMC Imaging Technology

Navitar Life Sciences has announced they have entered into a binding agreement to acquire assets of Modulation Optics and their Hoffman Modulation Contrast (HMC) Imaging Technology. moreFeb. 15, 2010

Stem Cell Biology

The view of a tumor as an aberrant tissue whose growth and differentiation is sustained by cancer stem cells is now largely accepted for a wide variety of cancer diseases. Cancer stem cells, as their physiological counterparts, possess the ability to control their fate by maintaining themselves in a quiescent and undifferentiated state or self-renewing to geometrically expand their number. more